204 related articles for article (PubMed ID: 24463419)
1. Sustained drug delivery in glaucoma.
Knight OJ; Lawrence SD
Curr Opin Ophthalmol; 2014 Mar; 25(2):112-7. PubMed ID: 24463419
[TBL] [Abstract][Full Text] [Related]
2. Sustained drug delivery for glaucoma: current data and future trends.
Aref AA
Curr Opin Ophthalmol; 2017 Mar; 28(2):169-174. PubMed ID: 27764023
[TBL] [Abstract][Full Text] [Related]
3. [Progression of drug delivery system for glaucoma].
Xu Y; Lyu L
Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
[TBL] [Abstract][Full Text] [Related]
4. Novel drug delivery systems for glaucoma.
Lavik E; Kuehn MH; Kwon YH
Eye (Lond); 2011 May; 25(5):578-86. PubMed ID: 21475311
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
6. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
[TBL] [Abstract][Full Text] [Related]
7. Sustained release ocular drug delivery systems for glaucoma therapy.
Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
9. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
10. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.
Chiang B; Kim YC; Doty AC; Grossniklaus HE; Schwendeman SP; Prausnitz MR
J Control Release; 2016 Apr; 228():48-57. PubMed ID: 26930266
[TBL] [Abstract][Full Text] [Related]
11. Barriers to glaucoma drug delivery.
Ghate D; Edelhauser HF
J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
[TBL] [Abstract][Full Text] [Related]
12. Current opinion in ophthalmology: novel glaucoma devices in the pipeline.
Ittoop SM; Seibold LK; Kahook MY
Curr Opin Ophthalmol; 2019 Mar; 30(2):117-124. PubMed ID: 30575619
[TBL] [Abstract][Full Text] [Related]
13. Sustained drug release by contact lenses for glaucoma treatment-a review.
Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
[TBL] [Abstract][Full Text] [Related]
14. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
Kompella UB; Hartman RR; Patil MA
Prog Retin Eye Res; 2021 May; 82():100901. PubMed ID: 32891866
[TBL] [Abstract][Full Text] [Related]
15. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
16. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
[TBL] [Abstract][Full Text] [Related]
17. New classes of glaucoma medications.
Schehlein EM; Novack GD; Robin AL
Curr Opin Ophthalmol; 2017 Mar; 28(2):161-168. PubMed ID: 27828896
[TBL] [Abstract][Full Text] [Related]
18. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
19. Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.
Holló G; Topouzis F; Fechtner RD
Expert Opin Pharmacother; 2014 Aug; 15(12):1737-47. PubMed ID: 24998246
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
Gupta S; Samanta MK
Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
